{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:40Z","timestamp":1761540340874},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2495,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2001,9,7]]},"abstract":"<jats:p>Inhibitor development is a serious complication in patients with haemophilia A and B. Historically, a lack of optimal therapies and factor products for treating inhibitor patients resulted in many patients developing chronic haemophilic arthropathies and flexion contractures of the involved joints. The introduction of immune\u2010tolerance protocols to eradicate high\u2010titre inhibitors has greatly diminished the incidence of these types of complications but as in the case reported here, immune tolerance is not always successful. Various elective surgical procedures were often delayed or not even considered in patients with inhibitor because of the variability in achieving adequate haemostasis and the thrombotic risks involved with the use of activated prothrombin\u2010complex concentrates (APCCs) over extended periods of time. The development of recombinant factor VIIa (rFVIIa; NovoSeven<jats:sup>TM<\/jats:sup>) and its demonstrated safety and efficacy in treating inhibitor patients has opened new possibilities for addressing severe arthropathy with flexion contracture. This case report demonstrates that the use of rFVIIa in such a situation must include dosing flexibility that is both patient\u2010specific and related to the potential for bleeding; the ability to maintain clinical haemostasis with a prophylactic dose of rFVIIa given as little as once daily; and the capacity for higher doses of rFVIIa, particularly in children because their kinetic profiles differ from adults.<\/jats:p>","DOI":"10.1046\/j.1365-2516.2001.00553.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:06:27Z","timestamp":1047423987000},"page":"517-522","source":"Crossref","is-referenced-by-count":69,"title":["Rationale for the use of high dose rFVIIa in a high\u2010titre inhibitor patient with haemophilia B during major orthopaedic procedures"],"prefix":"10.1111","volume":"7","author":[{"given":"H. A.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Campion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(98)00026-5"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199803000-00002"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615357"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1997.130135000.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00638.x"},{"key":"e_1_2_6_8_2","first-page":"773","article-title":"Home treatment of haemophilia","volume":"99","author":"Pabinger I","year":"1987","journal-title":"Wein Klin Wochenschr"},{"key":"e_1_2_6_9_2","first-page":"247","article-title":"Haemophilia home therapy","volume":"22","author":"Jones P.","year":"1992","journal-title":"Haemostasis"},{"key":"e_1_2_6_10_2","unstructured":"HilgartenMW CardiD GoldbergI.Home Therapy. In: Forbes CD Aledort L Madhok R eds.HaemophiliaLondon: Chapman & Hall Medical. 1997: 171\u201381."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615388"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.V58.1.38.38","article-title":"A procedure for removing high titre antibodies by extracorporeal protein\u2010A\u2010sepharose in a patient with haemophilia B and antibodies","volume":"58","author":"Nilsson IM","year":"1981","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804143181503"},{"key":"e_1_2_6_14_2","unstructured":"GlaznerS&HednerUet\u2003al.Clinical update on the use of recombinant factor VIIa. In: Aledort LM Hoyer LW Lusher JM Reisner HM White GC II eds.Inhibitors to Coagulation FactorsNew York: Plenum Press. 1995: 163\u201374."},{"key":"e_1_2_6_15_2","unstructured":"HednerU KristensenHI BerntorpE LjungR PetriniP TengbornL.Pharmacokinetics of rFVIIa in Children. World Federation of Haemophilia Conference Den Hague The Netherlands 1998 (Abstract)."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.80"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4463256.x"},{"key":"e_1_2_6_18_2","first-page":"21","article-title":"The effects of activated factor VII in a cell\u2010based model for tissue factor\u2010initiated coagulation","volume":"9","author":"Kjalke M","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"e_1_2_6_19_2","unstructured":"KjalkeM MonroeDM HoffmanM RobertsHR HednerU EzbanM.High\u2010dose factor VIIa restores platelet activation and total thrombin generation in a model system mimicking hemophilia A or B conditions.Thromb Haemost Suppl1999;August:303\u2013303."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/ort.1965.36.suppl-77.01"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V80.1.25.25","article-title":"Measurement of basal levels of factor VIIa in haemophilia A and B patients","volume":"80","author":"Wildgoose P","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(94)90227-5"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V95.4.1330.004k28_1330_1335","article-title":"Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of haemophilia A by Factor VIIa","volume":"95","author":"Van'T Veer C","year":"2000","journal-title":"Blood"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00553.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.2001.00553.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.2001.00553.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:53:27Z","timestamp":1697370807000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2516.2001.00553.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9,7]]}},"alternative-id":["10.1046\/j.1365-2516.2001.00553.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2516.2001.00553.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,7]]}}}